Grade Pharmaceutical 209216-23-9 Entecavir Monohydrate Don Maganin Hepatitis B

Takaitaccen Bayani:

Tsafta:≧99%, fari zuwa kashe-fari foda

Matsayin Inganci:A cikin gida ko kamar yadda ake bukata

Takaddun shaida:COA, MOA, MSDS, da dai sauransu

Iyawa:50Kg/wata

Rayuwar Shelf:Shekaru 2

Aikace-aikace:Wani magani da ake amfani da shi don magance ciwon hanta na kullum

Amfanin Ƙungiya:Ƙwararrun tallace-tallacen tallace-tallace na fitarwa tare da horarwar sana'a a masana'anta

Aika mana imel Zazzage azaman PDF

Cikakken Bayani

FAQ

Tags samfurin

Samfurasuna	Entecavir monohydrate
Makamantu	2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3- (hydroxymethyl) -2-methylenecyclopentyl]-6H-purin-6-daya monohydrate
CAS No.	209216-23-9
Bayyanar	Fari zuwa kashe-fari foda
Tsarin kwayoyin halitta	C₁₂H₁₅N₅O₃.H₂O
Nauyin Kwayoyin Halitta	295.30
Amfani	Matsayin Magunguna ko Manufar Bincike
Shiryawa	Kamar yadda kuka bukata
Adana	Ajiye a cikin matsi, kwantena masu jure haske a wuri mai sanyi

Entecavir monohydrate Cas: 209216-23-9
Abubuwa	Daidaitawa	Sakamako
Bayyanar	Fari zuwa kashe-fari foda	Ya bi
Juyawar gani	+24.0°—+28.0°(DMF:MeOH=1:1 c=1%)	+27.0°
Ganewa	A: Ta IR, Don dacewa da daidaitattun aiki	Ya bi
Ganewa	B: Ta HPLC, lokacin riƙewa yakamata ya dace da daidaitaccen aiki	Ya bi
Ruwa	5.8% - 6.5%	6.1%
Isomer	Single ≤0.1%	0.02%
Isomer	Jimlar ≤0.5%	0.02%
Abubuwa masu alaƙa	Najasa ɗaya ≤0.1%	0.05%
Abubuwa masu alaƙa	Jimlar ƙazanta ≤0.3%	0.07%
Ragowa akan kunnawa	≤0.1%	0.04%
Karfe masu nauyi	£10ppm	Ya bi
Ragowar kaushi	Ya kamata ya dace da ma'auni	Ya bi
Assay	≥99.8%	99.9%
Kammalawa:Ya bi ka'idodin cikin gida.

Bayanin Kamfanin

√ Cikakken ƙwarewar gudanarwa a masana'anta da ƙwararrun masu bin fasaha;
√ Quality ne ko da yaushe mu saman la'akari, M QC tsarin;
√ 11 shekaru gogaggen fitar da tallace-tallace tawagar;
√ R&D mai zaman kansa;
√ Biyu da aka sanya hannu na dogon lokaci na GMP;
√ wadataccen albarkatu na masana'antu marasa aiki da yawa don aikin da aka keɓance;
√ Ƙwararren aiki mai inganci tare da madaidaiciyar hanya.
imgsaf